4.6 Review

Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review

Journal

PSYCHO-ONCOLOGY
Volume 31, Issue 8, Pages 1275-1285

Publisher

WILEY
DOI: 10.1002/pon.5980

Keywords

adolescent and young adult; cancer; cancer survivors; cognitive dysfunction; cognitive impairment; oncology; psycho-oncology; review

Funding

  1. National Cancer Institute
  2. National Center for Advancing Translational Sciences

Ask authors/readers for more resources

This review examines the prevalence, associated factors, and impact of cancer-related cognitive impairments (CRCI) among adolescent and young adult (AYA) survivors of non-central nervous system (CNS) cancers. The findings suggest that CRCI is highly prevalent among AYA survivors and significantly affects their quality of life and role functioning. The review highlights the need for further research using longitudinal, imaging, and mixed methods, as well as the provision of resources to improve AYA survivors' quality of life and educational and occupational attainment. However, there is a lack of interventions specifically targeting CRCI in this population, and more studies are needed to explore the effectiveness of digital interventions.
Objectives Cancer-related cognitive impairments (CRCI) are common after treatment and can have important impacts on the lives of adolescent and young adult (AYA) cancer survivors-those cancer survivors diagnosed between ages 15 and 39. However, most research focuses on survivors diagnosed under age 15 or over age 39 so we know relatively little about CRCI among AYA survivors of non-central nervous system (CNS) cancers. Here we review the research on CRCI among AYA survivors of non-CNS cancers to determine prevalence, associated factors, and impact on survivors' lives as well as implications for future research. Methods In November 2021 we performed a systematic search of the literature in MEDLINE, Web of Science, PsycInfo, CINAHL, EMBASE, and Cochrane Central Register of Controlled Trials to identify peer-reviewed English language articles describing original research with at least one cognitive outcome and conducted with AYA survivors of non-CNS cancer diagnosed as AYAs. We screened 6003 articles and 21 met eligibility criteria. Guided by the PRISMA-ScR Checklist, we extracted study information to meet review objectives. Results Most studies employed cross-sectional surveys or interviews, though some employed longitudinal methods, neurocognitive assessments, or brain imaging. From the subset of articles that reported a prevalence we calculated a weighted mean prevalence of 25.75% and weighted median prevalence of 27.8%. The factors associated with CRCI included female gender, higher dose chemotherapy, and comorbidities. CRCI impacted the lives of AYA survivors through impaired role functioning, financial toxicity, and unmet needs. Conclusions CRCI is highly prevalent among non-CNS cancer survivors diagnosed as AYAs and impacts quality of life and role functioning. This review suggests a need for further longitudinal, imaging, and mixed methods research and provision of resources to help achieve better quality of life and educational and occupational attainment during what is potentially a decades-long survivorship period. However, although interventions might improve cognition and functioning, the review identified only one pilot study. Digital interventions may be a practical and effective option for this age group, but they have yet to be adequately investigated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available